A study analyzing the allelic frequency of single nucleotide polymorphisms (SNPs) in the coding sequences of CCL17 and CCL22 in MS patients, versus in healthy controls, indicated an association of SNPs in this chemokine cluster with MS risk, particularly in males [67]. Here, CCL22 is linked to myeloid sarcoma.